Cerament G Shows Outstanding Long-term Results

BONESUPPORT Cerament G Bone Graft Substitute

BONESUPPORT announced publication of mid- to long-term data confirming the sustained clinical effectiveness of CERAMENT G, an injectable drug-eluting bioceramic bone graft substitute, in a single-stage protocol to manage chronic osteomyelitis.

The study followed 100 patients. Results at a mean follow-up of 6.05 years were reported:

94% of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us